Lipoprotein profiles in human heterozygote carriers of a functional mutation P297S in scavenger receptor class B1

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1851, Issue 12, 2015, Pages 1587-1595

  Ljunggren, Stefan A ^a   Levels, Johannes H M ^b   Hovingh, Kees ^b   Holleboom, Adriaan G ^b   Vergeer, Menno ^b   Argyri, Letta ^c   Gkolfinopoulou, Christina ^c   Chroni, Angeliki ^c   Sierts, Jeroen A ^b   Kastelein, John J ^b   Kuivenhoven, Jan Albert ^d   Lindahl, Mats ^e   Karlsson, Helen ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e LINKÖPING UNIVERSITY   (Sweden)

Author keywords

ApoE; ApoL 1; HDL; LDL VLDL; P297S; SR B1

Indexed keywords

APOLIPOPROTEIN A1; ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHIONINE; OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR BI; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; PON1 PROTEIN, HUMAN; SCARB1 PROTEIN, HUMAN; SCAVENGER RECEPTOR B;

ADULT; AGED; ANIMAL CELL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FUNCTIONAL GENOMICS; GENE MUTATION; HETEROZYGOTE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; SEPARATION TECHNIQUE; TRIACYLGLYCEROL BLOOD LEVEL; TWO DIMENSIONAL GEL ELECTROPHORESIS; ULTRACENTRIFUGATION; WESTERN BLOTTING; AMINO ACID SUBSTITUTION; BLOOD; GENETICS; METABOLISM; MISSENSE MUTATION;

AMINO ACID SUBSTITUTION; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; FEMALE; HETEROZYGOTE; HUMANS; LIPOPROTEINS; MALE; MUTATION, MISSENSE; SCAVENGER RECEPTORS, CLASS B;

EID: 84945208146     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2015.09.006     Document Type: Article

References (45)

1. T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T.R. Dawber High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study Am. J. Med. 62 1977 707 714
2. D. Gordon, J. Probstfield, R. Garrison, J. Neaton, and et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies Circulation 79 1989 8 15
3. Emerging Risk Factors Collaboration E. Di Angelantonio, N. Sarwar, P. Perry, and et al. Major lipids, apolipoproteins, and risk of vascular disease JAMA 302 2009 1993 2000
4. P. Barter, B. Brewer, J. Chapman, C. Hennekens, and et al. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis Arterioscler. Thromb. Vasc. Biol. 23 2003 160 167
5. D. Masson, M. Koseki, M. Ishibashi, C. Larson, and et al. Increased HDL cholesterol and ApoA-I in humans and mice treated with a novel SR-B1 inhibitor Arterioscler. Thromb. Vasc. Biol. 29 2009 2054 2060
6. C. Danilo, J. Gutierrez-Pajares, M. Mainieri, I. Mercier, and et al. Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development Breast Cancer Res. 15 2013 R87
7. M. Van Eck, J. Twisk, M. Hoekstra, B.T. Van Rij, and et al. Differential effects of scavenger receptor B1 deficiency on lipid metabolism in cells of the arterial wall and in the liver J. Biol. Chem. 278 2003 23699 23705
8. A. Braun, B. Trigatti, M. Post, K. Sato, and et al. Loss of SR-B1 expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice Circ. Res. 90 2002 270 276
9. B. Trigatti, H. Rayburn, M. Vinals, A. Braun, and et al. Influence of the high density lipoprotein receptor SR-B1 on reproductive and cardiovascular pathophysiology Proc. Natl. Acad. Sci. U. S. A. 96 1999 9322 9327
10. A. Picataggi, G. Lim, A. Kent, J. Millar, and et al. A coding variant in SR-B1 (I179N) significantly increases atherosclerosis in mice Mamm. Genome 24 2013 257 265
11. H. Grallert, J. Dupuis, J. Bis, A. Deghan, and et al. Eight genetic loci associated with variationin lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies Eur. Heart J. 33 2012 238 251
12. A. Manichaikul, A. Naj, D. Herrington, W. Post, and et al. Association of SCARB1 variants with subclinical atherosclerosis and incident cardiovascular disease: the multi-ethnic study of atherosclerosis Arterioscler. Thromb. Vasc. Biol. 32 2012 1991 1999
13. A. Naj, M. West, S. Rich, W. Post, and et al. Association of scavenger receptor class B type I polymorphisms with subclinical atherosclerosis - the multi-ethnic study of atherosclerosis Circ. Cardiovasc. Genet. 3 2010 47 52
14. C. Verdier, L. Martinez, J. Ferrières, M. Elbaz, and et al. Targeting high-density lipoproteins: update on a promising therapy Arch. Cardiovasc. Dis. 106 2013 601 611
15. M. Vergeer, S. Korporaal, R. Franssen, I. Meurs, and et al. Genetic variant of the scavenger receptor B1 in humans N. Engl. J. Med. 364 2011 136 145
16. A. Chadwick, and D. Sahoo Functional characterization of newly-discovered mutations in human SR-BI PLoS One 7 2012 e45660
17. L. Brunham, I. Tietjen, A. Bochjem, R. Singaraja, and et al. Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans Clin. Genet. 79 2011 575 581
18. H. Karlsson, P. Leandersson, C. Tagesson, and M. Lindahl Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry Proteomics 5 2005 1431 1445
19. M. Lindahl, B. Ståhlbom, J. Svartz, and C. Tagesson Protein patterns of human nasal and bronchoalveolar lavage fluids analyzed with two-dimensional gel electrophoresis Electrophoresis 19 1998 3222 3229
20. 2 + precipitation procedure for quantitation of high-density-lipoprotein cholesterol Clin. Chem. 28 1982 1379 1388
21. M. Navab, S.Y. Hama, G.P. Hough, G. Subbanagounder, and et al. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids J. Lipid Res. 42 2001 1308 1317
22. G. Daniil, A.A. Phedonos, A.G. Holleboom, M.M. Motazacker, and et al. Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders Clin. Chim. Acta 412 2011 1213 1220
23. V. Tsimihodimos, S.A. Karabina, A.P. Tambaki, E. Bairaktari, and et al. Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB Arterioscler. Thromb. Vasc. Biol. 22 2002 306 311
24. R. Richter, G. Jarvik, and C. Furlong Determination of paraoxonase 1 status without the use of toxic organophosphate substrates Circ. Cardiovasc. Genet. 1 2008 147 152
25. A. Khera, M. Cuchel, M. de la Llera-Moya, A. Rodrigues, and et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N. Engl. J. Med. 364 2011 127 135
26. X. Li, W. Tang, M. Mosior, Y. Huang, and et al. Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks Arterioscler. Thromb. Vasc. Biol. 33 2013 1696 1705
27. K. Kitajima, D. Marchadier, G. Miller, G. Gao, and et al. Complete prevention of atherosclerosis in ApoE-deficient mice by hepatic human ApoE gene transfer with adeno-associated virus serotypes 7 and 8 Arterioscler. Thromb. Vasc. Biol. 26 2006 1852 1857
28. R. Tangirala, D. Praticó, G. Fitzgerald, and S. Chun Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E J. Biol. Chem. 276 2001 261 266
29. A. Rigotti, B. Trigatti, M. Penman, H. Rayburn, and et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type 1 reveals its key role in HDL metabolism Proc. Natl. Acad. Sci. U. S. A. 94 1997 12610 12615
30. S. Bultel-Brienne, S. Lestavel, A. Pilon, I. Laffont, and et al. Lipid free apoE binds to the class B type I scavenger receptor 1 (SR-B1) and enhances cholesteryl ester uptake from lipoproteins J. Biol. Chem. 277 2002 36092 36099
31. W. Annema, A. Dikkers, J. Freark de Boer, and et al. ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma J. Lipid Res. 5 2012 929 940
32. J.P. De Barros, A. Boualam, T. Gautier, L. Dumont, and et al. Apolipoprotein C1 is a physiological regulator of cholesteryl ester transfer protein activity in human plasma but not in rabbit plasma J. Lipid Res. 50 2009 1842 1851
33. W. De Haan, R. Out, J.F. Berbée, C.C. van der Hoogt, and et al. Apolipoprotein C1 inhibits scavenger receptor B1 and increases plasma HDL levels in vivo Biochem. Biophys. Res. Commun. 377 2008 1294 1298
34. T. Liu, W. Qian, M. Gritsenko, D. Camp, and et al. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry J. Proteome Res. 4 2005 2070 2080
35. B. Vanhollebeke, and E. Pays The function of apolipoproteins L Cell. Mol. Life Sci. 63 2006 1937 1944
36. P.N. Duchateau, C.R. Pullinger, R.E. Orellana, S.T. Kunitake, and et al. Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L J. Biol. Chem. 272 1997 25576 25582
37. L. Vanhamme, F. Paturiaux-Hanocq, P. Poelvoorde, D.P. Nolan, and et al. Apolipoprotein L-I is the trypanosome lytic factor of human serum Nature 422 2003 83 87
38. I. Kaoru, A. Bick, J. Flannick, and D. Friedman Increased burden of cardiovascular disease in carriers of APOL1 genetic variants Circ. Res. 114 2014 845 850
39. P.N. Duchateau, I. Movsesyan, S. Yamashita, N. Sakai, and et al. Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects J. Lipid Res. 41 2000 1231 1236
40. W.S. Davidson, R.A. Silva, S. Chantepie, W.R. Lagor, and et al. Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function Arterioscler. Thromb. Vasc. Biol. 29 2009 870 876
41. L.P. Precourt, D. Amre, M.C. Denis, J.C. Lavoie, and et al. The three-gene paraoxonase family: physiologic roles, actions and regulation Atherosclerosis 214 2011 20 36
42. S. Chantepie, A. Bochem, J. Chapman, K. Hovingh, and A. Kontush High-density lipoprotein (HDL) particle subpopulations in heterozygous cholesteryl ester transfer protein (CETP) deficiency: maintenance of antioxidative activity PLoS One 7 2012 e49336
43. B. Shao, G. Cavigiolio, N. Brot, M. Oda, and et al. Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I Proc. Natl. Acad. Sci. U S A. 105 2008 12224 12229
44. B. Shao, C. Tang, A. Sinha, P. Mayer, and et al. Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase Circ. Res. 114 2014 1733 1742
45. E. Favari, N. Ronda, M. Adorni, F. Zimetti, and et al. ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects J. Lipid Res. 54 2013 238 243